| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(96)80148-6 |
| P698 | PubMed publication ID | 8773918 |
| P50 | author | Pablo Muriel | Q57004674 |
| P2093 | author name string | P Muriel | |
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients | Q28379555 | ||
| Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction | Q29616762 | ||
| Gamma-interferon inhibits collagen synthesis in vivo in the mouse | Q34568345 | ||
| Selective inhibition of human diploid fibroblast collagen synthesis by interferons | Q34615618 | ||
| Vitamin A-containing lipocytes and formation of type III collagen in liver injury | Q35031663 | ||
| Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation | Q36350622 | ||
| Fibrogenic cytokines: the role of immune mediators in the development of scar tissue | Q37691116 | ||
| Is Cirrhosis of the Liver Experimentally Produced by CC14 an Adequate Model of Human Cirrhosis? | Q40144364 | ||
| Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial | Q41839327 | ||
| Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial | Q42008293 | ||
| Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B. | Q43650301 | ||
| Collagens of normal and cirrhotic human liver | Q44326690 | ||
| Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma | Q45998074 | ||
| An improved method for determining specific radioactivities of proline-14C and hydroxyproline-14C in collagen and in noncollagenous proteins | Q47884464 | ||
| Colchicine in the treatment of cirrhosis of the liver | Q49172380 | ||
| Immunohistochemical detection of proliferating lipocytes in regenerating rat liver. | Q50882087 | ||
| gamma-Glutamyltransferase in kidney brush border membranes. | Q52121099 | ||
| Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. | Q64932245 | ||
| Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy | Q67984653 | ||
| Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated with decreased levels of the procollagen mRNAs | Q69937501 | ||
| Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report | Q70313812 | ||
| Role of lipid peroxidation in biliary obstruction in the rat | Q72615416 | ||
| Effect of alpha-interferon on erythrocyte and hepatocyte plasma membranes derived from cirrhotic rats | Q72777618 | ||
| Protective effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach | Q72812628 | ||
| alpha-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers | Q72855200 | ||
| Reversibility of cholestatic changes following experimental common bile duct obstruction: fact or fantasy? | Q72855223 | ||
| Erythrocyte alterations correlate with CCl4 and biliary obstruction-induced liver damage in the rat | Q72948139 | ||
| REGENERATION OF LIVER AFTER BILIARY CIRRHOSIS | Q76625865 | ||
| Disturbances of structure and function in the liver as the result of biliary obstruction | Q78335116 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 614-621 | |
| P577 | publication date | 1996-05-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat | |
| P478 | volume | 24 |
| Q28374071 | Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells |
| Q59353017 | Apoptosis and liver fibrosis: antifibrotic strategies |
| Q74336131 | Changes in histological lesions and serum fibrogenesis markers in chronic hepatitis C patients non-responders to interferon alpha |
| Q44911228 | Cholestasis-induced fibrosis is reduced by interferon alpha-2a and is associated with elevated liver metalloprotease activity |
| Q40444779 | Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells |
| Q59353022 | Effects of long-term administration of interferon α in two models of liver fibrosis in rats |
| Q44746112 | Effects of silymarin and vitamins E and C on liver damage induced by prolonged biliary obstruction in the rat. |
| Q34269628 | Hepatic fibrosis. Pathogenesis and principles of therapy |
| Q44373702 | In vivo inefficiency of pentoxifylline and interferon-alpha on hepatic fibrosis in biliary-obstructed rats: assessment by tissue collagen content and prolidase activity |
| Q77594863 | Liver damage induced by acute cholestasis in the rat is ameliorated partially by L-arginine |
| Q30697447 | Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis |
| Q73207429 | Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat |
| Q44419930 | Role of manganese accumulation in increased brain glutamine of the cirrhotic rat. |
| Q34208873 | Triplex forming oligonucleotides against type α1(I) collagen attenuates liver fibrosis induced by bile duct ligation |
Search more.